Thursday, February 06, 2020 9:30:52 AM
https://www.researchsquare.com/article/f73e8460-86c9-43e4-930a-838aae7e8d16/v2
Currently Article Status - Under Review
Version 2 Posted January 29th, 2020
Background section of article:
Currently, Thapsigargin become a research hotspot of the anticancer drug Mipsagargin,[color=red][/color] and it is TenctlyThapsia garganica CYP76AE2 that mediates the conversion of epikunzeaol to epidihydrocostunolide compounds which are possible intermediates in thapsigargin biosynthesis [6
Recent RBSH News
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/21/2023 09:19:43 PM
- Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB • Edgar (US Regulatory) • 08/14/2023 08:36:33 PM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM